The BHMEDS-R3 app is designed as a quick reference for non-prescriber behavioral health professionals and consumers who need general knowledge about medications prescribed for behavioral health conditions. The language has been modified to increase readability for a larger audience and, in keeping with the goal of continuously updating the app content, new medications are added after FDA approval. Download the FREE app using the QR codes below.
Use the BHMEDS-R3 app for the following:
Originally developed as a companion piece to the Mid-America ATTC curriculum, A Collaborative Response: Addressing the Needs of Consumers with Co-Occurring Substance Use and Mental Health Disorders (2000), this publication is now available as a downloadable PDF and replicates the content included in the new BHMEDS-R3 app now available in the Apple App Store and Google Play.
Back by popular demand, this 10th Edition publication is acclaimed for its accessibility as an educational reference for addiction professionals, patients, and families. Educators and addiction counselor training programs across the United States have asked that we continue to update and publish a downloadable publication to reflect the same credible and up-to-date information included in the BHMEDS-R3 app. We attempt to update the BHMEDS-R3 app content annually and publish an updated publication biannually.
Name brand medications have a limited patent. When the patent expires, the medication may be made as a generic. The generic name of a medication is the actual name of the medication and never changes. A generic medication may be made by many different manufacturers and can make several forms of a single medication with only slight variations in color, size, or shape.